Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Recurrent Head and Neck Cancer · Metastatic Head and Neck Cancer · PDSB

PDS Biotechnology

PDS Biotechnology Corp

PDS Biotechnology patent portfolio — 11 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Princeton, USA HQ
2005 Founded
32 Employees
Public company Type
PDSB · NYSE Ticker
Company details
Status
Public
HQ
Princeton, USA
Founded
2005
Employees
32
Programs
3
Drugs
5
Patents
11
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

PDS Biotechnology patents

11 pharmaceutical patents indexed for PDS Biotechnology. 1 expire within 24 months.

PDS Biotechnology has 11 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

11 patents

Patent portfolio

  1. US 11911359

    Stimulation of an immune response by cationic lipids

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11911465

    Vaccine compositions and methods of use

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11904015

    Vaccine compositions and methods of use

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11801257

    Stimulation of an immune response by enantiomers of cationic lipids

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11638753

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11612652

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10702541

    Stimulation of an immune response by enantiomers of cationic lipids

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9789129

    Stimulation of an immune response by enantiomers of cationic lipids

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8877206

    Stimulation of an immune response by cationic lipids

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7303881

    Antigen delivery compositions and methods of use

    Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does PDS Biotechnology have?

11 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do PDS Biotechnology patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.